Lonnel Coats Blueprint Medicines Corp (BPMC) insider trading activity

Lonnel Coats is of Blueprint Medicines Corp. Currently has a direct ownership of 2,242 shares of BPMC, which is worth approximately $200,434. The most recent transaction as insider was on Nov 21, 2024, when has been sold 9,824 shares (Common Stock) at a price of $94.87 per share, resulting in proceeds of $932,002. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 2.24K

83.08% 3M change

79.64% 12M change

Total Value Held $200,434

LONNEL COATS Transaction History

Date	Transaction	Value	Shares Traded	Shares Held
Nov 21 2024	SELL Open market or private sale	$932,002 $94.87 p/Share	9,824 Reduced 81.42%	2,242 Common Stock
Nov 20 2024	SELL Open market or private sale	$941,300 $94.13 p/Share	10,000 Reduced 45.32%	12,066 Common Stock
Nov 20 2024	BUY Exercise of conversion of derivative security	$643,364 $73.01 p/Share	8,812 Added 28.54%	22,066 Common Stock
Jun 12 2024	BUY Grant, award, or other acquisition	-	2,242 Added 14.47%	13,254 Common Stock
Jun 21 2023	BUY Grant, award, or other acquisition	-	2,600 Added 19.1%	11,012 Common Stock
Jun 21 2022	BUY Grant, award, or other acquisition	-	2,600 Added 23.61%	8,412 Common Stock
Jun 02 2021	BUY Grant, award, or other acquisition	-	2,250 Added 27.91%	5,812 Common Stock

Also insider at

LXRX

LEXICON PHARMACEUTICALS, INC. Healthcare

Chief Executive Officer

VERV

Verve Therapeutics, Inc. Healthcare

Lonnel Coats

Cambridge, MA

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells BPMC shares.

Notify only if

Value

Insider Trading

Get notified when an Blueprint Medicines Corp insider buys or sells BPMC shares.

Notify only if

Operation

Value

Type

News

Receive news related to Blueprint Medicines Corp

Track Activities on BPMC

Account